Cooper Companies | COO - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Bausch Health Companies USD -802M 1.26B 2026-06
Baxter International USD 6.21B 163M 2026-06
Bayer EUR 29.71B 863M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.33B 89.1M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Haemonetics USD 837.1M 40.78M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.42B 119.6M 2026-06
Integra LifeSciences USD 1.04B 971K 2026-06
Intuitive Surgical USD 18.17B 693.9M 2026-06
J&J USD 84.97B 3.78B 2026-06
Medtronic USD 50.23B 160M 2026-06
Merit Medical Systems USD 1.68B 53.08M 2026-06
Novartis USD 38.93B 7.2B 2026-03
ResMed USD 6.59B 93.48M 2026-06
STAAR Surgical USD 365.4M 13.03M 2026-06
Steris USD 7.21B 23.1M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Utah Medical Products USD 120.37M 1.1M 2026-03
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06